We are international
• health professionals TEXT SIZE   
webcasts    back

Dr. Reeder - Phase II Trial of Myeloma Induction Therapy with Cyclophosphamide, Bortezomib, and Dexamethasone (Cybor-D): Improved Response over Historical Lenalidomide-Dexamethasone Controls
Craig B. Reeder, MD
Mayo Clinic
Scottsdale, Arizona

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles